Qube Research & Technologies LTD Beyond Spring Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.76 - $3.6 $4,400 - $9,000	-2,500 Reduced 96.01%	104 $0
Q1 2024 May 14, 2024	BUY	$0.85 - $3.63 $2,125 - $9,075	2,500 Added 2403.85%	2,604 $9,000
Q3 2023 Nov 13, 2023	BUY	$0.75 - $1.16 $78 - $120	104 New	104 $0
Q3 2022 Nov 14, 2022	SELL	$0.97 - $1.81 $3,361 - $6,271	-3,465 Reduced 14.82%	19,909 $20,000
Q2 2022 Aug 15, 2022	BUY	$1.13 - $2.66 $26,412 - $62,174	23,374 New	23,374 $34,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.